Nurix Therapeutics (NRIX) Announces Extension of Strategic Collaboration with Sanofi (SNY) to Develop Novel Targeted Protein Degraders of STAT6

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. IBM
5. META
6. MU
7. ACN
8. NVDA
9. BLZE
10. PRIM

Go back to Nurix Therapeutics (NRIX) Announces Extension of Strategic Collaboration with Sanofi (SNY) to Develop Novel Targeted Protein Degraders of STAT6
(NASDAQ: NRIX) Delayed: 18.86 +0.21 (1.13%)
Previous Close $18.65    52 Week High $ 
Open $18.49    52 Week Low $ 
Day High $19.12    P/E N/A 
Day Low $18.39    EPS $ 
Volume 1,547,021       

SANOFI (NASDAQ: SNY) Delayed: 41.60 -0.18 (0.43%)
Previous Close $41.78    52 Week High $44.76 
Open $42.27    52 Week Low $36.81 
Day High $42.47    P/E N/A 
Day Low $41.47    EPS $0.00 
Volume 10,563,122